Brian Wilson, MD
Allergy · Tallahassee, FLNPI 1760433247
Payments from drug & device makers
Across 622 payments — averaging $18.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- GSK$2K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Regeneron Healthcare Solutions, Inc.$993
- CSL Behring$780
- Sanofi$636
- plus $4K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 99 | $1,867 |
| GSK | 102 | $1,635 |
| Takeda Pharmaceuticals U.S.A., Inc. | 53 | $1,015 |
| Regeneron Healthcare Solutions, Inc. | 58 | $993 |
| CSL Behring | 49 | $780 |
| Sanofi | 31 | $636 |
| Novartis | 32 | $576 |
| Pfizer | 25 | $446 |
| Genentech USA, Inc. | 23 | $434 |
| Amgen(2 entities) | 21 | $401 |
| Grifols USA, LLC | 20 | $300 |
| Kaleo, Inc. | 17 | $299 |
| Pharming Healthcare, Inc. | 16 | $282 |
| Octapharma USA, Inc. | 8 | $245 |
| Biocryst US Sales Co., LLC | 9 | $197 |
| Alk-abello, Inc | 8 | $122 |
| Shire North American Group Inc | 6 | $107 |
| ADMA Biomanufacturing LLC | 3 | $102 |
| LEO Pharma Inc. | 5 | $99 |
| Optinose US, Inc. | 4 | $81 |
| Ionis Pharmaceuticals, Inc. | 3 | $81 |
| Teva Pharmaceuticals USA, Inc. | 4 | $77 |
| Merck | 4 | $66 |
| Sanofi-aventis U.S. LLC | 1 | $65 |
| Incyte Corporation | 4 | $63 |
| Blueprint Medicines Corporation | 3 | $58 |
| Aimmune Therapeutics, Inc. | 3 | $57 |
| Hikma Pharmaceuticals USA | 3 | $51 |
| Lilly USA, LLC | 2 | $47 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $42 |
| AbbVie | 1 | $26 |
| Paratek Pharmaceuticals, Inc. | 1 | $23 |
| Biocryst Pharmaceuticals, Inc. | 1 | $20 |
| Circassia Inc. | 1 | $12 |
How this compares
$11,306 in reported general payments places this provider in the 80th percentile of 56 allergy providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy in Tallahassee
- Randolph MaloneTallahassee$3K
- Hugh WindomSarasota$3.6M
- Miguel LanzCoral Gables$1.4M
- Brett StanalandNaples$575K
- Alan KoterbaNorth Palm Beach$367K
- David RoseEglin Afb$253K
- Shahid RandhawaFort Lauderdale$91K
- Carlos PiniellaMiami$61K
- Pavana BeerelliRockledge$61K
- Patrick de MarcoOrange Park$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.